First Quadrant’s ResMed RMD Stock Holding History

First Quadrant’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-178	Closed	-$46K	–	450
2021 Q4	$46K	Hold	178	–	–	﹤0.01%	412
2021 Q3	$47K	Hold	178	–	–	0.01%	412
2021 Q2	$44K	Hold	178	–	–	0.01%	409
2021 Q1	$35K	Buy	+178	New	+$35.7K	﹤0.01%	482
2017 Q1	–	Sell	-102	Closed	-$6K	–	838
2016 Q4	$6K	Buy	+102	New	+$6.25K	﹤0.01%	816
2016 Q3	–	Sell	-391,100	Closed	-$24.7M	–	906
2016 Q2	$24.7M	Buy	391,100 +97,100	+33%	+$5.72M	0.55%	47
2016 Q1	$17M	Buy	+294,000	New	+$16.6M	0.37%	92
2015 Q4	–	Sell	-400	Closed	-$20K	–	827
2015 Q3	$20K	Hold	400	–	–	﹤0.01%	736
2015 Q2	$23K	Hold	400	–	–	﹤0.01%	733
2015 Q1	$29K	Hold	400	–	–	﹤0.01%	693
2014 Q4	$22K	Hold	400	–	–	﹤0.01%	709
2014 Q3	$20K	Hold	400	–	–	﹤0.01%	748
2014 Q2	$20K	Hold	400	–	–	﹤0.01%	754
2014 Q1	$18K	Hold	400	–	–	﹤0.01%	697
2013 Q4	$19K	Hold	400	–	–	﹤0.01%	726
2013 Q3	$21K	Hold	400	–	–	﹤0.01%	729
2013 Q2	$18K	Buy	+400	New	+$19K	﹤0.01%	738

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

First Quadrant's RMD Position: Q1 2022 in Review

First Quadrant sold out of ResMed (RMD) in Q1 2022, closing a stake of 178 shares — an estimated $46K sold.

First Quadrant first reported a position in RMD in Q2 2013 and held it in 17 quarters. The position peaked at $24.7M in Q2 2016. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

First Quadrant reported no remaining ResMed position as of Q1 2022 after selling out during the quarter.
First Quadrant sold 178 ResMed shares in Q1 2022, an estimated $46K.
First Quadrant first reported a position in ResMed in Q2 2013 and held it in 17 quarters.
First Quadrant's ResMed position peaked at $24.7M in Q2 2016.
682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.